Cargando…
Drug Repurposing for COVID-19 using Graph Neural Network with Genetic, Mechanistic, and Epidemiological Validation
Amid the pandemic of 2019 novel coronavirus disease (COVID-19) infected by SARS-CoV-2, a vast amount of drug research for prevention and treatment has been quickly conducted, but these efforts have been unsuccessful thus far. Our objective is to prioritize repurposable drugs using a drug repurposing...
Autores principales: | Hsieh, Kanglin, Wang, Yinyin, Chen, Luyao, Zhao, Zhongming, Savitz, Sean, Jiang, Xiaoqian, Tang, Jing, Kim, Yejin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743080/ https://www.ncbi.nlm.nih.gov/pubmed/33330858 http://dx.doi.org/10.21203/rs.3.rs-114758/v1 |
Ejemplares similares
-
Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence
por: Hsieh, Kanglin, et al.
Publicado: (2021) -
A computational approach to drug repurposing using graph neural networks
por: Doshi, Siddhant, et al.
Publicado: (2022) -
Counterfactual analysis of differential comorbidity risk factors in Alzheimer’s disease and related dementias
por: Kim, Yejin, et al.
Publicado: (2022) -
Explainable drug side effect prediction via biologically informed graph neural network
por: Huang, Tongtong, et al.
Publicado: (2023) -
Synthesize heterogeneous biological knowledge via representation learning for Alzheimer’s disease drug repurposing
por: Hsieh, Kang-Lin, et al.
Publicado: (2022)